Antidepressant market usher in new opportunities, see "a brother" status fall to who hand? 2023-05-11
Analysis of 70 macrocyclic drugs approved by the FDA 2023-05-11
$860 million market size, PDC drug development market analysis 2023-05-11
Only 3 drugs have been approved! Frozen life, Times="32".16 million worth of drugs 2023-05-11
Enbio: Partnered with BioNTech to advance the development of next-generation antibody conjugated drugs (ADCs) 2023-04-20
Cure diabetes obesity with printed materials? Novo Nordisk Introduces Cell Therapy for
.6 billion 2023-04-20
Multiple product indications withdrawn, FDA accelerated Approval How to reform? 2023-04-20
Maxpro: Completed merger with SPAC Maxpro listed on Nasdaq 2023-03-31
Meinol completed the B round financing of over 100 million yuan, continued to accelerate the overall layout of CXO industry 2023-03-31
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma 2023-03-31
Yi Neng Pharmaceutical, A leading TCM CXO enterprise, has completed a series of financing of over 100 million yuan, enabling the modernization innovation research development of TCM 2023-03-31
After 20 years of failure, Is there Hope for targeted Aβ therapy for AD? 2023-03-20
$161 million! China Biopharmaceutical completes acquisition of F-star Therapeutics 2023-03-10
The different paths of Chinese foreign diabetes giants: double males double bears 2023-03-03
Sanofis cracked quadrivalent influenza virus vaccine, VaxigripTetra?, was approved for sale in China 2023-03-03
Star ADC Therapy DS-8201 approved for market in China! 2023-03-03
Star ADC Therapy DS-8201 approved for market in China! 2023-03-01
For the first time, heparin was incorporated into the country, which ushered in a change in the ten-billion market 2023-03-01
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR 2023-02-16
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure 2023-02-16
Tronsound long-acting IL-36R antibody obtained FDA clinical IND 2023-02-16
Hua Quejing Medical has received tens of millions of yuan of exclusive investment from Shenzhen Venture Capital continues to lead the intelligent development of rehabilitation robots 2023-02-10
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful 2023-02-10
Is the class solidified? From Biotech to Pharma 2023-02-10
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia 2023-02-10
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR 2023-02-10
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure 2023-02-10
Tronsound long-acting IL-36R antibody obtained FDA clinical IND 2023-02-10
9 million people develop diabetes, which is strongly associated with this risk factor! 2023-01-12
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials 2023-01-12
When the most prevalent mutant strain in the United States, it was detected in China 2023-01-12
2022 FDA approval of new drug transcript 2023-01-12
共
1463 个 页次:
1 /
46 页
32 个/页
首页 上一页 下一页 尾页
转到：
第1页
第2页
第3页
第4页
第5页
第6页
第7页
第8页
第9页
第10页
第11页
第12页
第13页
第14页
第15页
第16页
第17页
第18页
第19页
第20页
第21页
第22页
第23页
第24页
第25页
第26页
第27页
第28页
第29页
第30页
第31页
第32页
第33页
第34页
第35页
第36页
第37页
第38页
第39页
第40页
第41页
第42页
第43页
第44页
第45页
第46页
Our Advantages of Reports
①All reports written by ourselves
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
News 
